Eurand Inks Deal With Daewoong To Market Muscle Relaxant in Korea
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Eurand has signed a license and distribution agreement with Daewoong Pharmaceutical to launch extended-release muscle relaxantAmrix (cyclobenzaprine) in Korea, the Milan-based company announced Aug. 1